New York Governor Kathy Hochul recently announced that the Big Apple recently reached $1 billion in cannabis retail sales.
Ending 2024, New York closed out the year by rolling in $1 billion in retail sales for the state’s cannabis industry, according to New York Governor Kathy Hochul (1). In 2021, cannabis in New York was legalized for recreational use but over the last few years it has been rolled out very slowly and created a “gray” market and due to this slow rollout cannabis businesses struggled to get their hands on licenses (2,3).
The New York cannabis industry was also slow to rollout since its inaugural year due to the overhaul of the Office of Cannabis Management (OCM) (1,4).
“Earlier this year, my administration took critical steps to promote progress and economic opportunity within New York's budding cannabis industry, including signing new enforcement powers into law that expedited the closure of unlicensed storefronts and, as a result, bolstered our legal market,” Governor Hochul commented (1). She further added, “Today, we recognize the $1 billion milestone as more than just a number—it’s a testament to the hard work of those who helped build the strongest cannabis industry in the nation: one that prioritizes equity, ensures public safety, and empowers communities.”
Office of Cannabis Management acting director, Felicia A.B. Reid said (1), “This milestone is a testament to the resilience, hard work, and innovation of cannabis entrepreneurs across New York. As $1 billion is an incredible number. Let us celebrate the individuals, businesses, and communities in cannabis who drive our state’s economic engine.” Reid additionally mentioned, “Certainly, this moment underscores the strength of consumer demand for regulated cannabis—more importantly, it firmly demonstrates that a social and economic equity approach to industry is not antithetical to strong economic growth. New Yorkers have placed their trust in a market that prioritizes equity—and OCM remains committed to supporting that mission.”
In the press release, it disclosed that over half of the adult-use licenses that have been given out, were provided to Social and Economic Equity applicants (1), a significant portion were women-owned and minority establishments. Aside from the applications, the cannabis industry in New York State has witnessed significant growth in cannabis consumption. Throughout the last 10 years, 19% of New York consumers reported annual use which is up 30%. 12% of consumers shared that they consume monthly and is up 43% over the last decade and lastly, the press release mentioned that 67% of consumers that had consumed cannabis over the last year were purchasing their products from legal retail establishments (1). By acquiring their products in legal businesses, it shows that consumers are feeling confident “in the regulated market” (1).
“New York’s cannabis industry was designed with a focus on equity and opportunity, and today’s achievement is proof that our approach is working. By prioritizing Social and Economic Equity applicants, we’re creating a market that uplifts communities and fosters meaningful economic impact across the state,” Tremaine Wright, chairwoman of the Cannabis Control Board, mentioned (1). “The tax revenue generated by this thriving industry directly supports our Community Reinvestment Grant Program, ensuring that communities disproportionately impacted by cannabis prohibition receive critical investments. This is only the beginning of what’s possible when we invest in an inclusive and well-regulated industry.”
“As the Buffalo Bill's coach says, ‘Trust the process.’ Things will continue to improve and be refined, but New York State's Office of Cannabis Management (OCM) has established a solid foundation towards the success of its infant cannabis industry. Congratulations to OCM staff, the advocates, and the backbone of it all, New York's cannabis supply chain of small businesses, in surpassing this milestone,” Crystal Peoples-Stokes, Assembly Majority Leader, explained (1).
The announcement of New York reaching its $1 billion retail sales milestone wasn’t the only good news witnessed. The OCM Annual Report was released and showcased some of 2024’s highlights.
As the press release mentions, below are some of the highlights that can be found in the OCM Annual Report (1,5):
2024 in Review
EQUITY + COMMUNITY PARTNERSHIPS + TRAINING
MEDICAL CANNABIS
ENFORCEMENT
To read more about the OCM 2024 Annual Report, please click here (5).
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Khan
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.